AAB
UTHR icon

ABN AMRO Bank’s United Therapeutics UTHR Stock Holding History

ABN AMRO Bank’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.42M Buy
+7,444
New +$3.71M 0.05% 119

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

ABN AMRO Bank's UTHR Position: Q1 2026 in Review

ABN AMRO Bank opened a new position in United Therapeutics (UTHR) in Q1 2026: 7,444 shares worth $4.42M. The stake represents 0.05% of the portfolio and ranks #119 among its holdings.

850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • ABN AMRO Bank held 7,444 shares of United Therapeutics worth $4.42M as of Q1 2026.
  • United Therapeutics was a new ABN AMRO Bank position in Q1 2026.
  • United Therapeutics made up 0.05% of ABN AMRO Bank's portfolio in Q1 2026, its #119 holding.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on ABN AMRO Bank's 13F filing for Q1 2026, filed 22 Apr 2026.